Market Access Consulting
Accelerate access with integrated, Canadian-based expertise
We help you see what others miss
At Innomar, we’re embedded in the Canadian healthcare system. Our integrated services, spanning everything from logistics to commercialization and beyond, provide a connected, end-to-end view of how therapies move through care.
The result? Fewer missed opportunities. Greater alignment. Faster paths to success.
How we help
Market access strategy
Navigate Canadian market entry with confidence. Build tailored strategies that align pricing, reimbursement, and product listing goals to position your product for success.
- Conduct market research and landscape assessments
- Develop pricing strategies for public and private payers
Stakeholder engagement
Patient access hinges on the insights and influence of key voices. Drive the success of your market access strategy by fostering meaningful partnerships with key opinion leaders and other vital stakeholders. Engage their expertise and perspectives to shape decisions that enhance patient access and outcomes.
- Facilitate advisory meetings that drive actionable insights
- Map stakeholders and create tailored engagement plans
- Educate stakeholders on inputs for health technology assessment (HTA) and provincial plans
Drug pricing strategy and analysis
Strategic pricing is critical to your product’s success. Navigate Canada’s complex regulatory, HTA and pan-Canadian Pharmaceutical Alliance (pCPA) frameworks with ease to avoid costly missteps and secure sustainable pricing.
- Develop strategic pricing plans aligned with Canadian regulations
- Analyze pricing scenarios to optimize outcomes
- Leverage expertise in pCPA strategy development and negotiations
Health technology assessment and payer submissions
Your product deserves a strong case for reimbursement. Deliver compelling, evidence-based submissions that meet the rigorous expectations of Canadian payers and HTA agencies.
- Develop comprehensive HTA submissions
- Align value messaging to evolving Canadian review frameworks
- Manage full or partial submission processes
Health economics and outcomes research (HEOR)
Show the true value of your product. Strengthen your story with impactful health economic modeling, publication planning, and strategy development.
- Build pharmacoeconomic models tailored for Canadian submissions
- Create budget impact analyses (BIAs) that align with payer expectations
- Adapt global economic models for the Canadian market
- Support study development (e.g. observational and burden-of-illness studies) and publications to elevate your value proposition
Real-world evidence (RWE)
Real-world evidence is vital to demonstrating your product’s value. Strengthen the value proposition of your product by integrating RWE into your market access strategy through collection of actionable data to guide smarter decisions.
- Design and execution of prospective and retrospective studies
- Develop patient-reported outcomes strategies
- Collect cost and resource utilization data
- Integrate RWE generation into patient support programs
Medical device and diagnostic commercialization
Success in the Canadian market starts with a clear plan. Position your device or diagnostic for adoption by meeting regulatory and reimbursement requirements.
- Define tailored regulatory and reimbursement strategies
- Address companion diagnostic considerations to align with therapeutic goals
- Conduct comprehensive pricing assessments to optimize market access
